A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis (RR-MS)

NCT03387046 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Study was terminated early due to slow recruitment rate.

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

DIETARY_SUPPLEMENT: D-aspartate
DRUG: Placebo
BIOLOGICAL: IFN beta-1a
DRUG: Methylprednisolone

Sponsor

Merck KGaA, Darmstadt, Germany